Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

AKBA holding history

Akebia Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings

Shares (Q2 2026)
38,568
Value
$44.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AKBA by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202638,568$44.0K<0.1%+7,424+23.8%AddedHolders
Q1 202631,144$43.3K<0.1%+3,894+14.3%AddedHolders
Q4 202527,250$43.9K<0.1%−89,850−76.7%ReducedHolders
Q3 2025117,100$319.7K<0.1%00.0%UnchangedHolders
Q2 2025117,100$426.2K<0.1%−9,000−7.1%ReducedHolders
Q1 2025126,100$242.1K<0.1%+32,750+35.1%AddedHolders
Q4 202493,350$177.4K<0.1%00.0%UnchangedHolders
Q3 202493,350$122.0K<0.1%+5,000+5.7%AddedHolders
Q2 202488,350$89.0K<0.1%+15,000+20.4%AddedHolders
Q1 202473,350$135.0K<0.1%−23,000−23.9%ReducedHolders
Q4 202396,350$119.0K<0.1%+1,000+1.0%AddedHolders
Q3 202395,350$109.0K<0.1%+25,000+35.5%AddedHolders
Q2 202370,350$65.0K<0.1%00.0%UnchangedHolders
Q1 202370,350$40.0K<0.1%+10,925+18.4%AddedHolders
Q4 202259,425$34.0K<0.1%+7,401+14.2%AddedHolders
Q3 202252,024$16.0K<0.1%+6,300+13.8%AddedHolders
Q2 202245,724$16.0K<0.1%−2,958−6.1%ReducedHolders
Q1 202248,682$35.0K<0.1%−110.0%ReducedHolders
Q4 202148,693$110.0K<0.1%00.0%UnchangedHolders
Q3 202148,693$141.0K<0.1%−450−0.9%ReducedHolders
Q2 202149,143$187.0K<0.1%00.0%UnchangedHolders
Q1 202149,143$167.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.